Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer
PR Newswire•28/09/2026•16:05 ET
0
Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer PR Newswire
SAN DIEGO, Sept. 28, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Eiry W. Roberts, M.D., who previously served as Neurocrine's Chief Medical Officer and currently serves as a Strategic Advisor, will rejoin the Company's executive management team as Chief Medical Officer (CMO), effective immediately. By mutual agreement, Sanjay Keswani, M.D., will depart the Company.
Get started
Create a free account to read the full story and Whiz Insights.